Filing Details

Accession Number:
0001209191-17-025766
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-05 17:26:24
Reporting Period:
2017-04-04
Filing Date:
2017-04-05
Accepted Time:
2017-04-05 17:26:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1016169 Antares Pharma Inc. ATRS Surgical & Medical Instruments & Apparatus (3841) 411350192
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1054942 F Robert Apple C/O Antares Pharma, Inc.
100 Princeton South, Suite 300
Ewing NJ 08628
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-04-04 37,000 $1.65 927,002 No 4 M Direct
Common Stock Disposition 2017-04-04 37,000 $3.00 890,002 No 4 S Direct
Common Stock Acquisiton 2017-04-05 3,000 $1.65 893,002 No 4 M Direct
Common Stock Disposition 2017-04-05 3,000 $3.00 890,002 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-04-04 37,000 $0.00 37,000 $1.65
Common Stock Stock Option (right to buy) Disposition 2017-04-05 3,000 $0.00 3,000 $1.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,000 2017-05-10 No 4 M Direct
0 2017-05-10 No 4 M Direct
Footnotes
  1. The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. The exercised stock option reported on this Form 4 was due to expire on May 10, 2017.
  2. The options vested and became exercisable in equal quarterly installments over three years following the grant date of May 10, 2007.